PRESS RELEASE published on 03/17/2026 at 07:03, 4 months 15 days ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius Stedim Biotech sharpens focus on biopharma with new growth targets and strategic initiatives to drive above-market growth and margin expansion Sartorius Stedim Biotech Strategic Initiatives Growth Targets Biopharma Above-market Growth
BRIEF published on 03/02/2026 at 16:30, 4 months 30 days ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
BRIEF published on 03/02/2026 at 16:30, 4 months 30 days ago Sartorius Stedim Biotech: Share Capital and Voting Rights Update Share Capital Voting Rights French Commercial Code Sartorius Stedim Biotech EQS News Service
PRESS RELEASE published on 03/02/2026 at 16:25, 4 months 30 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of February 28, 2026 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
PRESS RELEASE published on 02/16/2026 at 09:13, 5 months 13 days ago Sartorius Stedim Biotech releases Universal Registration Document 2025 Sartorius Stedim Biotech releases Universal Registration Document 2025, providing insights into its financial performance and strategic outlook for the future Financial Report Sartorius Stedim Biotech Annual Results Universal Registration Document Biopharma Industry
BRIEF published on 02/16/2026 at 09:13, 5 months 13 days ago Sartorius Stedim Biotech Releases 2025 Universal Registration Document Global Operations Sartorius Stedim Biotech Universal Registration Document Biopharmaceutical Solutions 2025 Financials
BRIEF published on 02/16/2026 at 09:13, 5 months 13 days ago Sartorius Stedim Biotech publishes its 2025 Universal Registration Document Consolidated Financial Statements Sartorius Stedim Biotech Universal Registration Document Fiscal Year 2025 2026 Objectives
PRESS RELEASE published on 02/16/2026 at 09:09, 5 months 13 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech releases Universal Registration Document 2025 with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Business Development Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document
PRESS RELEASE published on 02/16/2026 at 09:08, 5 months 13 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group's Universal Registration Document 2025 now available at the provided link. Includes fiscal 2025 business development, 2026 forecast, and financial statements Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document 2025
BRIEF published on 02/06/2026 at 11:50, 5 months 23 days ago Sartorius Stedim Biotech Proposes Steady Dividend for 2025 Biotech Industry Dividend Proposal Sartorius Stedim Biotech Annual Shareholders' Meeting 2025 Financial Results
Published on 08/01/2026 at 01:20, 17 hours 21 minutes ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 17 hours 26 minutes ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 18 hours 11 minutes ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 19 hours 21 minutes ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/01/2026 at 16:35, 2 hours 5 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 22 hours 46 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 23 hours 36 minutes ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:53, 23 hours 47 minutes ago Deutsche EuroShop SE: Conversion into a European Company Successfully Completed
Published on 07/31/2026 at 21:00, 21 hours 41 minutes ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 23 hours 13 minutes ago Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:13, 23 hours 27 minutes ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
